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A wide variety of anti-T-globulin factors have been demonstrated in human 
sera.  The  serological and  physicochemical properties  of most of these  factors 
are  known  in  considerable  detail,  whereas  others  have  been  less  well  char- 
acterized. 
The so called rheumatoid factors consist of 19S ~,M-globulins  which in whole serum 
form a 22S complex through interaction with ~'G-globulin (1, 2). Various test systems 
demonstrate an array of different factors that partly can be separated by absorption 
and  elution  procedures  (3-5).  These  factors react  with  the  Fc fragment of rabbit 
and/or human "},G-globulin (6--8). 
Rheumatoid  factors in some human sera  demonstrate  genetic factors on human 
~,G-globulin  (9,  10).  These  "anti-Gm  factors" react  with  the  Fc fragment  of ~'G- 
globulin  (11-13).  The serological  properties  of anti-Gm  factors in  rheumatoid  and 
non-rheumatoid  sera  are  distinct  (14,  15);  in  the latter  case,  they may be  typical 
isoantibodies resulting from stimulation by foreign type ~,G-globulin  introduced by 
blood transfusions (16) or transplacental passage (17-19). 
It is  not  clear whether  "anti-Inv factors"  should  be  called  rheumatoid  factors. 
They are,  at least in the majority of cases,  found in non-rheumatoid sera and react 
with determinants present in the Fab fragment of "yG-globulin  (11,  12). Other anti- 
~-globulin  factors  reacting  with  determinants  present  on  the  light  chains  of ~,G- 
globulin  have  recently been  described  by Williams  (20).  Tanned  cells  coated with 
isolated light chains of human "yG-globulin are agglutinated by some rheumatoid sera. 
This agglutination is inhibited by isolated light chain preparations, but not by intact 
~,G-globulin,  indicating that the factors react with determinants  that are hidden in 
the intact molecule. 
Milgrom et al.  (21)  observed that some human sera agglutinated red cells  coated 
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with incomplete anti-Rh antibodies, and that the agglutination was not inhibited by 
addition of  pooled  human  "yG-globulin. The  latter  phenomenon  showed  that  the 
active substance was serologically  distinct from rheumatoid factors. Sera with identical 
serological properties were  described independently by  Grubb  (9)  under  the  term 
"non-rheumatoid type agglutinators". The  term "anti-antibody"  was used by Mil- 
groin et at. (21). More recent data indicate, however, that a wide variety of substances 
are able to interact with antibody -y-globulin in such a way that they logically might 
be referred to as anti-antibodies. It is felt, therefore, that the term "anti-antibody" 
should not be restricted to only one of these substances. Until more complete char- 
acterizafion of the various substances is achieved, it is suggested that a  more non- 
eommital designation be used. To  denote the factor originally referred to as "anti- 
antibody"  by  Milgrom et  aI.  (21),  we  shall  use  the  term  "Milgrom  type  anti- 
-r-globulin". 
Finally, Osterland et al. (8) observed that some human sera were able to agglutinate 
red cells sensitized with pepsin-digested incomplete anti-Rh antibodies, whereas they 
did not  agglutinate cells sensitized with  intact anti-Rh  antibody. The  responsible 
factor could be separated from the other anti-3,-globulin factors by several techniques. 
It did not react with native 7G-globulin but apparently with a hidden determinant 
that was exposed by digestion with pepsin or papain at low pH. 
The  present  investigations were  undertaken  to  compare  the  properties of 
various anti-'r-globulin factors in human  sera.  Rheumatoid  factors,  Milgrom 
type  anti-'y-globulin factors,  and  antibodies  directed  against  an  enzyme  re- 
vealed antigen in human ~G-globulin were studied. It was demonstrated that 
the hidden antigen was exposed, not only by the somewhat artificial procedure 
of enzymatic digestion at low pH, but also when human ~G-globulin functioned 
as antibody in an antigen-antibody precipitate. The  results obtained indicate 
that the three different forms of anti--3,-globulin factors may all be produced 
as a  result of antigenic stimulation by autologous antigen-antibody complexes. 
Materials and Methods 
Human Sera.--"Normal sera" were obtained from healthy blood donors. About 750 sera 
from a  "mixed hospital population" were tested. These patients had been admitted to the 
surgical and medical departments of Oslo City Hospital for a variety of disorders,  and sera 
were obtained in connection  with blood typing or compatibility tests prior to blood trans- 
fusion. They were screened for the presence of Milgrom type anti-~-globulin factors using red 
cells coated with three different  anti-Rh antibodies selected  for reasons given  below. Five 
potent sera (Be., En., He., Ni., Sv.) were found and used in the present investigations. Rheum- 
atoid sera were obtained through the courtesy of Dr. V. Laine of The Rheumatism Foun- 
dation Hospital, Heinola, Finland. They were from patients with rheumatoid arthritis having 
peripheral, symmetrical joint lesions, and positive Waaler-Rose and latex fixation reactions. 
The sera were selected on the basis of these criteria since patients with similar joint lesions and 
negative serological reactions often appear to suffer from  other diseases  than  rheumatoid 
arthritis (22). The sera were stored in small aliquots at -- 25°C until used. 
Tests for Rheumatoid Factors.--The Waaler-Rose  and latex fixation tests were performed by 
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incomplete anti-Rh antibodies were performed on slides. Three drops were introduced in each 
reaction; one drop of the serum dilution, one drop of saline, and one drop of coated red cells. 
The titres are given as reciprocals of the dilutions of sera when introduced into the mixture. 
In inhibition tests, the drop of saline was replaced by one drop of the material to be tested for 
inhibiting capacity. In most experiments, the extra drop of 3~-globulin in saline at a concen- 
tration of 1 mg/ml was added to a  series of dilutions of serum. The agglutination titre was 
recorded and compared with that of the control sample where only saline was added. In some 
instances, a  fixed  dilution of serum containing 8  to  l0 agglutinating doses was tested with 
serial dilutions of the material to be examined for inhibiting capacity. Controls were always 
included as in inhibition experiments for determination of Gm types (24). 
Coating of Red  Cells with  Various A~tibody  Preparatians.--Coating  of red cells with in- 
complete anti-Rh antibodies was performed as previously described  (27).  Red ceils coated 
with anti-CD Ripley were used for the detection of rheumatoid factor since this reagent is 
known to react with most rheumatoid factors. For reaction with Milgrom type anti-tic-globulin 
factors, cells coated with incomplete anti-Rh antibodies Ho.,  Hu.,  Lo.,  and Ni. were used. 
These anfisera were selected since cells coated in this way had previously been shown to react 
with only a minority of rheumatoid factors and at the same time to react well with Milgrom 
type anti-'y-globulin factors. 
To obtain anti-A and anti-B antibodies of 3'G- and  'yM-giobulin  type  from  the  same 
serum,  an individual of group  O  was immunized with blood group  AB substance  (Merck 
Sharp and Dohme, Amsterdam, The Netherlands) as described elsewhere (25). One part of 
the  serum  was  fractionated  by  DEAE  cellulose  chromatography and a  pure 3"G-globulin 
fraction was obtained. Another part of the serum was subjected to gel filtration on a sephadex 
G-200 column to obtain the macrogiobulin fraction (26). Group AIB red cells were subsequently 
sensitized  with  various  subagglutinating  doses  (~,  ~,  z/~, and  ~s  of  the  minimum 
agglutinating dose) of the two kinds of isoagglutinins. Agglutination tests with  these  ceils 
and selected sera were performed on slides using pooled normal, rheumatoid factor-free serum 
as control. 
Coating  of  red  cells with pepsin-digested  anti-CD  Ripley  was  performed  as  described 
elsewhere (8),  and only some details on the present preparation are given. The 3'-giobulin 
fraction of serum Ripley was obtained by precipitation with (NH4)~.SO4 and subsequently 
digested  with pepsin (pepsin,  2  times crystallized,  Worthington Biochemical Corporation, 
Freehold, New Jersey) at pH 4.1. After digestion, precipitin tests in gel with specific anti-Fab 
and anti-Fc antisera indicated that the Fc part of the 3~G-globulin  molecule had been com- 
pletely destroyed whereas the Fab part was intact. The reactions of cells coated with whole 
anti-CD Rip]ey were then compared with those of cells coated with the pepsin-digested anti- 
CD  Ripley:  agglutination tests using serial dilutions of  the anti-Fab  serum  and  varying 
amounts of antibody to coat the cells,  showed that the agglutination was equally strong of 
cells coated with pepsin-digested anti-CD Ripley as of cells coated with ~-giobulin isolated 
from serum Ripley and exposed to low pH only. In marked contrast, anti-Fc did not aggluti- 
nate red cells coated with the pepsin-digested antibody, whereas cells coated with whole anti- 
CD Ripley were strongly agglutinated. To get optimal conditions for comparative analyses, 
only one preparation of pepsin-digested anti-CD Ripley was used for the experiments to be 
described in this paper. Mter the digestion and the various controls had been completed, the 
material was divided in small aliquots and stored at --25°C. Each sample was thawed only 
once for coating of red cells.  In parallel with the digestion of isolated 3c-globulin  from serum 
Ripley, a sample of pooled human "yG-globulin (AB Kabi, Stockholm, Sweden) was digested 
under identical conditions. Mter digestion, this preparation could no longer inhibit a reference 
anti-Gm(a) serum which is an additional indication that the digestion had been complete (8). 
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Human  ",/G-globulin  was  obtained  commercially  from  AB  Kabi.  Soluble  "y-globulin 
aggregates were prepared  by heating  or by treatment  with  mercaptoethanol  and  urea  as 
described by Edelman et al. (27). 
Reduction  by  Mercaptoethanol.--Serum  was  diluted  1:2  in  saline.  2-Mercaptoethanol 
(Finka AG, Buchs,  Switzerland) was added  to a  final concentration of 0.15  ~t followed by 
incubation overnight at room temperature. 
DEAE  Cellulose Chromatography was performed using cellulose N,N-diethylaminoethyl 
ether (Eastman Organic Chemicals, Rochester, New York)  and a  stepwise elution technique 
with phosphate buffers of pH 6.8 of varying molarity. The fractions representing each peak of 
eluted protein were pooled and tested for the various serological activities after concentration 
by ultrafiltration and dialysis against  saline.  Tests for purity were performed by immuno- 
electrophoresis using an anti-whole human  serum (Behringwerke AG., Marburg-Lahn,  Ger- 
many) and by diffusion in gd techniques with antisera specific for each of the immunoglobulins. 
Density Gradient Ultracentrifugation was carried out by the technique described by Kunkel 
et al. (28). 
Antisera.--Rabbit  antisera were obtained by immunization with purified protein prepa- 
rations in complete Freund's adjuvant. By various absorption procedures, the antisera were 
made specific for "yG-, 3'A- and "yM-globulin respectively. This was verified by diffusion  in gel 
experiments with whole human serum and the respective purified proteins. Anti-Fab was ob- 
tained by immunization with pepsin-digested ~'G-giobulin (8). The resulting antiserum gave 
a single line with whole human serum by immunoelectrophoresis and did only precipitate with 
the Fab  fragment  after papain  digestion of human "yG-globulin.  Anti-Fc was obtained by 
absorption  of an  anti--'yG-globulin with  pepsin-digested  "yG-giobulin.  Its  specificity  was 
verified by  immunoelectrophoretic analyses  with  intact  and  papain-digested  ~/G-globulin. 
Human  diphtheria  antitoxin  was  obtained  by  immunization  of  volunteers  as  previously 
described  (29).  Eight  different antisera  were used  and  these gave identical results  in  the 
absorption experiments to be described. 
Absorption  Experiments.--For  absorption  experiments  with  cells  sensitized  with  "yG- 
globulin antibodies, cells were coated as described above. Aliquots of a  serum containing a 
Milgrom type anti-T-globulin factor were diluted  1:2  and  mixed  with  equal  volumes of 
cells sensitized with the anti-Rh antibodies and  with  the  anti-AB  antibodies  (the  latter 
corresponding  to  a/~  of minimum  agglutinating  dose).  Mter  2  hours'  incubation  at  room 
temperature  the  supernatants  were  obtained  by  eentrifugation  and  tested  for  serological 
activity in parallel with controls that had been exposed to non-sensitized cells. 
For  absorption  experiments  with  cells sensitized  with "yM-globulin  antibodies,  human 
anti-Salmonella O was used. These antibodies are known to belong to the 19S class in most 
cases (30). One convalescent serum with an anti-O titer of 500 was used. It was verified that 
its agglutinating ability was completely abolished by reduction with mercaptoethanol. Three 
ml of Salmonella group B (1, 4, 5, 12) O suspension,  corresponding to 60 ml of the OB antigen 
suspension used in the Widal reaction for Salmonella agglutinins (31) and 3 ml of convalescent 
serum were incubated for 2 hours at 37°C,  followed by washing three times in saline. The 
packed, sensitized bacteria were used for absorption of 0.2 ml of each of two sera for 2 hours 
at room temperature. The supernatants were collected by centrlfugation and tested for aggluti- 
nating ability in parallel with controls that had been exposed  to non-sensitized bacteria. 
For absorption experiments with antigen-antibody precipitates containing rabbit antibody, 
quantitative precipitin curves were set up to define the conditions of maximal precipitation. 
Antigen and the corresponding antiserum were then mixed in these proportions. The precipi- 
tates were collected by centrifugation and washed three times in saline to be used for absorp- 
tion. Techniques for preparation  of precipitates consisting of diphtheria toxoid and human 
antitoxin are described elsewhere (29). Three mg of washed, packed precipitate were incubated MORTEN  HARBOE,  BARBARA RAU~ AND  1~1"a~O AHO  507 
with 0.1 ml of serum and 0.1 ml of saline overnight at room temperature. Care was taken to 
obtain an even suspension of precipitate in the serum to get optimal conditions for absorption. 
Controls consisted of sera incubated with saline alone under identical conditions. 
EXPERIMENTS  AND  RESULTS 
Properties of Milgrom Type Anti-T-Globulin Faaors.--Five sera were found 
that  agglutinated  red  cells  sensitized  with  any  of  seven  strong  incomplete 
anfi-Rh  antibodies.  Incubation  of unsensitized  cells and  incomplete anti-Rh 
serum with these sera resulted in agglutination identical with that obtained by 
using washed, previously sensitized  cells. The agglutination was not inhibited 
by addition of pooled human 7C--globulin. These properties are identical with 
those of the sera originally  described by Milgrom et al. (21). 
In  all  cases,  reduction  with  mercaptoethanol  resulted  in  complete loss  of 
agglutinating  ability, indicating that the active substance was a ~,M-globulin 
(28).  Confirmation was sought by exposing the sera to density gradient ultra- 
centrifugation  and  DEAE  cellulose  chromatography.  In  each  case,  activity 
was recovered only from the fractions that contained "yM-globulin. 
A series of experiments were designed  to see whether the active substance 
reacted with the Fab or the Fc part of 7G-globulin. 
Inhibition  experiments were made using 7G-globulin that had been aggre- 
gated in various ways. As described,  pooled human -~,G-globulin did not inhibit 
the agglutination.  ~tG-Globulin  aggregated by heating  or by treatment  with 
mercaptoethanol  and  urea  also  had  only  minimal  inhibiting  capacity.  By 
adding these materials in a concentration of 1 mg/ml to each of serial twofold 
dilutions of sera containing potent Milgrom type anti-v-globulin factors, the 
agglutination  titre remained  unchanged  or was reduced only one step.  As a 
control, rheumatoid sera were tested similarly  using cells coated with anti-CD 
Ripley as indicator. In this instance,  the aggregated "yG-globulin preparations 
reduced the titre 7 to 8 steps. Attempts were made to aggregate isolated Fab 
fragments, but no significant  inhibiting ability was obtained. 
"yG- and 7M-globulins cross-react because of common antigenic determinants 
which are located on the Fab part of ~/G-globulin (32, 33). Agglutination and 
absorption experiments with red cells sensitized  with antibodies belonging  to 
different  immunoglobulin  classes  might  therefore  give valuable information. 
The ability of an anti-~,-globulin  factor to interact with cells sensitized  with 
both ~,G- and "yM-globulin antibodies would indicate reactivity with the Fab 
part,  whereas  reaction  only  with  cells  coated  with  "yG-globulin  antibodies 
would indicate reactivity with the Fc part of "rG-globulin which is specific for 
this protein. 
Group  O  individuals  were immunized  with  blood group  substance and  a 
serum with high  titre anti-A  and  anti-B  antibodies was subjected to gel fil- 
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tized  with  ~/G-type  anti-AB  were  agglutinated  by  Milgrom  type  anti-'y- 
globulin factors, whereas no reactivity was observed with the cells coated with 
~,M-globulin anti-AB. 
Similar  absorption experiments were  then performed. Red  cells  sensitized 
with  "yG-globulin  antibodies  (incomplete  anti-Rh  antibodies  and  anti-AB 
antibodies  isolated  by  chromatography)  did  absorb  Milgrom  type  anti-'},- 
globulin factors.  1 For evaluation of ~,M-globulin antibodies, Salmonella group B 
bacteria sensitized with -/M-globulin type anti-O  antibodies were used.  Ab- 
sorption of the same sera with this material did not reduce the titre. 
Pepsin digestion of human ~G-globulin and similar type specific antibodies 
results in a fragment with antibody activity that structurally is very similar 
to the isolated Fab fragment after papain digestion (8). Agglutination experi- 
ments using Rh positive red cells coated with incomplete anti-Rh antibodies, 
or such antibodies digested with pepsin, thus provide a useful means for com- 
parison of interactions between various agglutinating  factors and  the whole 
-},-globulin molecule or the isolated Fab fragment. The reactivity of sera with 
Milgrom type anti-'y-globulin factors and  cells coated with anti-CD  Ripley 
or pepsin-digested anti-CD Ripley was therefore tested. The five selected sera 
agglutinated red cells coated with whole anti-CD  Ripley. The agglutination 
was not inhibited by -},G-globulin or by pepsin-digested "yG-globulin.  The sera 
did  also  agglutinate  red  cells  coated  with  pepsin-digested  anti-CD  Ripley. 
Inhibition experiments were made to characterize the substance responsible for 
the latter type of agglutination. It was observed that this agglutination was not 
inhibited by native "yG-globulin,  whereas pepsin-digested ~G-globulin had  a 
marked inhibiting capacity. These findings indicated that each serum contained 
two distinct anti--v-globulin factors. 
To obtain a fraction that only contained the Milgrom type anti-'y-globulin 
factor, attempts were made to separate the  two types of activity from indi- 
vidual sera. The behavior of such a  fraction against the two types of coated 
cells might then give valuable information. 
Fig. 1 illustrates the findings on serum En. where a complete separation was 
obtained.  Activity against  cells  coated with pepsin-digested  anti-CD  Ripley 
was recovered in the first 3 peaks. The first peak contained only "yG-globulin. 
The activity in the second peak was attributed to the content of ~,G-globulin in 
this fraction. The third peak contained the  bulk of the serum's ~,A-globulin 
and  had  a  marked  agglutinating  activity  against  cells  coated  with  pepsin- 
t Absorption with the relatively small amount of cells sensitized with incomplete  anti-Rh 
antibodies abolished the  agglutinating activity  against ceils sensitized with the  anti-Rh 
antibodies, leaving the agglutinating activity against ceils sensitized with the anti-AB anti- 
bodies essentially unchanged and vice versa. Thus it seems that the Milgrom type anti-~y  - 
globulin factor in a single serum may consist of a heterogeneous  population of molecules  that 
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digested anti-CD  Ripley. The  titre  was higher  than  that  of the  first peak. 
Experiments  using antisera  that react specifically with 3,G-globulin indicated 
that  the  third  peak  contained  about  1/100  of  the  amount  of 3,G-globulin 
present in the first peak.  Considering  the titers, it was therefore judged that 
the  agglutinating  ability resided  in  the  ~'A-globulin.  Agglutinating  activity 
against cells coated with whole anti-CD Ripley was confined to the fourth peak 
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FIG. 1. Fractionation of serum En. by DEAE cellulose chromatography. The various frac- 
tions were tested for protein content by precipitin tests with antisera reacting specifically with 
the three main immunogiobulins and for serological activity by various agglutination tests as 
indicated. 
which contained the bulk of the serum's "/M-globulin.  Repeated experiments 
confirmed  the observation that  the agglutinating  factor  recovered with  this 
peak reacted with red cells coated with whole anti-CD  Ripley, whereas cells 
coated with pepsin-digested anti-CD Ripley were not agglutinated. This finding 
again indicated that the Milgrom type anti-'r-globulin factor reacted with the 
Fc fragment of 3,G-globulin. 
Properties of Agglutinator  Active Against  Cells Coated witk Pepsin Digested 
Anti-CD Ripley.--Since only limited information is available (9), a survey was 
made for this agglutinator in various types of sera.  To save reagents, the sera 
were tested only in dilution 1:5 and the reactions were read after 10 minutes' 510  ANTI-~-GLOBULIN  FACTORS  IN  HUMAN  SERA 
incubation.  This  was  considered feasible  since  no  prozone phenomenon has 
been observed so far with this type of agglutinator. The results are summarized 
in Table I. It appears that the frequency of this agglutinator was fairly low in 
sera of blood donors, whilst it occurred about  twice as often in sera from a 
mixed hospital population. Sera from patients with rheumatoid arthritis often 
contained the factor. A striking observation was that all of the five sera with 
a  Milgrom  type  anti-q,-globulin  factor  also  contained  potent  agglutinators 
active against cells coated with pepsin-digested anti-Rh antibody. 
Inhibition  experiments  confirmed  the  previous  observations  (8)  that  the 
agglutination is not inhibited by intact 7G-globulin but only by "rG-globulin 
digested with pepsin or papain at low pH. This behavior sharply distinguishes 
this  agglutinator  from  other  anti-'v-globulin  factors.  At  a  concentration  of 
TABLE I 
Occurrence of A gglutinator A ctive against Red Cells Coated 
with Pepsin-Digested  Anti-CD Ripley 
Sera 
Blood donor sera 
Mixed hospital population sera 
Rheumatoid arthritis sera 
Sera with Milgrom type anti-'y-globulin factors 
+++ 
agglutination 
at dilution 1  : 5 
!)er cen~ 
5 
10 
45 
100 
++  or 
stronger 
agglutination 
at dilution 1  : 5 
~r  csnt 
17 
2O 
66 
Total n 
100 
140 
60 
5 
1  mg/ml,  3'G-globulin  aggregated  by  heating  or  treatment  with  mercapto- 
ethanol  and  urea did  not  significantly inhibit  the  agglutination  of red  cells 
coated with pepsin-digested anti-CD Ripley. 
Treatment of sera with mercaptoethanol gave various results. In some cases, 
complete loss of agglutinating ability was observed. In other cases, there was a 
reduction in titre or no effect. This is illustrated in Table II. These findings are 
different from those on rheumatoid factors and Milgrom type anti-v-globulin 
factors which are included in the table for comparison. The latter two activities 
were uniformly destroyed by reduction. 
Chromatography of selected sera showed that Milgrom type anti-h,-globulin 
factors and rheumatoid factor activity were only present in the fractions con- 
taining -/M-globulin. Agglutinating activity against  cells coated with pepsin- 
digested anti-CD Ripley could be recovered with fractions containing immuno- 
logically pure -yG-globulin. It was also recovered with fraction 3 of serum En. 
(cf.  Fig.  1).  This fraction contained q~A-globulin and only trace amounts  of 
-)'G-globulin which  could not account for the  activity. Finally,  this  type of 
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activity against cells coated with pepsin-digested anti-CD Ripley was found in 
all three classes of immunoglobulins. These observations confirm and extend 
previous density gradient nltracentrifugation experiments which revealed the 
activity in both the 7S and 19S fraction of human sera (8). 
Comparison of Various Anti-'y-Globulin Factors by Absorption Experiments.-- 
Absorption  experiments  were  made  to  compare  the  reactivity of  the  three 
different types of anti-3,-globulin factors: 
TABLE II 
Effect of Reduction by Mercaptoethanol (ME)  on 
Various Anti-~ -Globulin Factors 
Mflgrom type~  anti-3,-  Agglutination  of cells 
coated with pep~in-digestec  Rheumatoid factor*  globulin factor  anti-CD Ripley 
Serum 
control  ME  control  ME  control  ME 
Ja. 
Li. 
Je. 
Gu. 
He. 
Ni. 
Be. 
En. 
Sv. 
512 
128 
64 
128 
Neg. II 
¢c 
tc 
gc 
<2 
<2 
<2 
<2 
Neg. § 
gc 
gt 
64 
32 
32 
32 
32 
<2 
<2 
<2 
<2 
<2 
32 
16 
64 
8 
64 
16 
64 
64 
64 
4 
8 
32 
8 
<2 
<2 
2 
16 
32 
* Waaler-Rose test. 
:~ Agglutination of red cells coated with anti-Rh Lo. 
§ No agglutination at dilution 1:2 or higher. 
II No agglutination at dilution 1:8 or higher. 
First, antigen-antibody precipitate containing rabbit antibody (egg albumin/ 
rabbit anti-egg albumin) was used for absorption. The results are summarized 
in Table HI. As expected (3, 4) activity in the Waaler-Rose test was markedly 
reduced by this procedure, whereas activity in the latex fixation test was only 
slightly reduced.  Milgrom  type  anti--v-globulin factor activity and  aggluti- 
nation of red cells coated with pepsin-digested antibody remained unchanged. 
Secondly, precipitate containing human antibody (diphtheria toxoid/human 
antitoxin) was used. In this instance, the activity of rheumatoid sera in both 
the Waaler-Rose and latex fixation tests was markedly reduced. Milgrom type 
anti-v-globulin  factor  activity  could  also  be  absorbed  with  this  antigen- 
antibody precipitate. Repeated experiments on a  variety of sera showed that 
the  agglutinating  activity against  cells coated with pepsin-digested  anti-CD 
Ripley was easily removed by absorption with this type of antigen-antibody 
complex. As may be seen from Table IV, this was observed with sera that con- 512  ANTI-'y-GLOBULIN  FACTORS  IN  HUMAN  SERA 
TABLE  III 
Absorption Experiments with Antigen-Antibody Precipitates Containing Rabbit 
Antibody (Egg Albumin~Rabbit Anti-Egg Albumin) 
Serum 
Dr. 
Jo. 
9486 
9964 
En. 
Ni. 
Sv. 
Rheumatoid factors 
Latex fixation  test 
Control 
2560 
2560 
Neg. * 
Neg. 
Waaler-Rose test 
Absorbed 
i 
2560 
64O 
Control  Absorbed 
320 
640 
Neg.:~ 
Neg. 
~c 
20 
40 
Agglutination of cell 
Milgrom type anti-  coated  with pepsin- 
T-globulin  digested anti-CD 
factor  Ripley 
Control  Absorbed 
Neg.~ 
64  64 
16  16 
32  16 
Control  Absorbed 
128  64 
64  32 
32  16 
32  16 
32  32 
16  16 
32  32 
* Negative at dilution 1 : 10 or higher 
:~ Negative as defined in Table II. 
TABLE  IV 
Absorption Experiments with Antigen-Antibody Precipitates Containing Human 
Antibody (Diphtheria Toxoid/IIuman Antitoxin) 
Serum 
Dr. 
Jo. 
99 
251 
553 
680 
9486 
9964 
En. 
Ni. 
Sv. 
Rheumatoid factors 
Latex fixation test  Waaler-Rose  test 
Control  Absorbed  Control 
2000 
4000 
Neg.* 
~c 
Neg. 
cg 
40  512 
40  512 
Neg.* 
1 
lc 
!  Neg. 
I  " 
Absorbed! 
64 
64 
Milgrom type anti- 
"),-globulin  factor 
Control  Absorbed 
m 
Neg.* 
I 
32  <2 
32  <2 
32  2 
Agglutination of ceils 
coated with pepsin- 
digested anti-CD 
Ripley 
Control  I Absorbed 
256  <2 
64  <2  i 
32  <2 
64  2 
64  <2 
32  <2 
64  <2 
64  2 
32  <2 
32  <2 
64  <2 
* Negative as defined in Tables II and III. 
tained  only  this  type  of  anti-3'-globulin factor,  and  with  sera  that  also  con- 
tained  other  anti-'r-globulin  factors.  Inhibition experiments  using  similar,  or 
many  times  greater,  concentrations  of  diphtheria  toxoid  alone  demonstrated 
that antigen alone had no inhibiting capacity. Thus  it appears that  the hidden 
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laboratory conditions of enzymatic digestion at low pH, but also when human 
*tG-globulin acts as antibody in an antigen-antibody precipitate. 
Finally, absorption experiments were performed with antigen-antibody pre- 
cipitates which contained human *tG-globulin as antigen  (human *tG-globulin/ 
rabbit anti-Fab). As shown in Table V, rheumatoid factors were easily absorbed 
by this  type of antigen-antibody precipitate,  whereas Milgrom  type anti-*t- 
globulin  factor  activity  and  agglutination  of  red  cells  coated  with  pepsin- 
digested anti-CD Ripley remained unchanged. Additional control experiments 
showed that  the  difference  in  absorbing  capacity  of precipitates  containing 
TABLE V 
Absorption Experiments  with Anligen-Antibody  Precipitates Containing Human 
*tG-Globulin as Antigen  (Human *tG-Globulin/Rabbit Anti-Fab) 
Serum 
Dr. 
Jo. 
9486 
9492 
9964 
En. 
Ni. 
Sv. 
Rhemnatoid fsctors 
Latex fixstion test  Wssler-Rose test 
Control 
2560 
5120 
Neg.* 
lc 
Neg. 
Lg 
Absorbed 
20 
20 
Control  Absorbed 
320  40 
6t-0  40 
Neg.* 
Neg. 
lc 
lc 
Milgrom type snti- 
~,-globulln 
Control  Absorbed 
Neg.* 
32  16 
32  16 
32  32 
Agglutination of ceil: 
coated with pepsin- 
digested  anti-CD 
Pdpley 
Control 
128 
64 
32 
32 
32 
32 
32 
32 
Absorbed 
256 
64 
32 
64 
64 
32 
64 
64 
* Negative as defined in Tables II and III. 
human -rG-globulin  as antibody and antigen  respectively was not caused by 
differences  in the amount of 3'G-globulin  present in the two instances.  These 
experiments confirm  the inhibition  experiments with aggregated  human 3'G- 
globulin: whereas a variety of procedures which aggregate human *tG-globulin 
make it  reactive with rheumatoid  factors,  apparently more specific changes 
that occur when the *t-globulin molecule functions as antibody in an immune 
complex are needed to confer upon it ability to interact with the other two kinds 
of anti-*t-globulin  factors. 
DISCUSSION 
It was observed independently by Grubb (9) and Milgrom et al.  (21) that 
some human sera agglutinate  red cells coated with incomplete anti-Rh  anti- 
bodies, and that the agglutination is not inhibited by addition of *tG-globulin. 
The active substance was  called  "anti-antibody"  by Milgrom et  al.  since the 
serological  properties indicated that  it reacted with antibody *t-globulin only 514  ANTI--'~-GLOBULIN  FACTORS  IN"  ttKJ'M.AN" SERA 
when certain structural modifications had occurred as a result of its interaction 
with the corresponding antigen. 
Various immunochemical data also indicate that structural modifications of 
the antibody molecule occur as a result of the antigen-antibody interaction: an 
increase  in  the  apparent volume of the antibody molecules, similar to  that 
obtained in protein denaturation by other means, has been observed (34, 35) as 
well as an increase in optical levorotation (36). Robert and Grabar (37) titrated 
SH  groups in  horse  antibodies to human serum albumin and to Salmonella 
gallinarum polysaccharide. The antibodies in the antisera were partially purified 
and showed no titratable thiol groups.  In the presence of antigen, however, 
there was a slow exposure of a small amount of titratable SH groups. 
Autologous -r-globulin denaturated by various physicochemical procedures 
is antigenic (38--40), and the same is the case for autologous antigen-antibody 
complexes. Immunization with various forms of autologous antigen-antibody 
complexes leads to the formation of anti-~-globulin antibodies with properties 
very similar to human rheumatoid factors (40--44). 
The present experiments confirm that structural changes occur in antibody 
-r-globulin as a result of its interaction with the corresponding antigen. Oster- 
land, Harboe, and Kunkel (8)  detected in some human sera an agglutinating 
substance  active  against  red  cells  coated  with  pepsin-digested  incomplete 
anti-Rh antibodies. The agglutinator had many of the properties characteristic 
of antibodies and reacted with determinants on the Fab part of human 7G- 
globulin that were hidden in the intact molecule and exposed by enzymatic 
digestion at  low pH.  The  absorption  experiments  with  specific  precipitates 
consisting of diphtheria  toxoid and human antitoxin (cf.  Table  IV)  demon- 
strated that this hidden antigen is also exposed when human 7G-globulin acts 
as  antibody  in  an immune precipitate.  The  hidden antigen is,  however, not 
exposed when 7-globulin is present as antigen in the precipitate (cf. Table V). 
The hidden antigen is exposed on 7G-globulin molecules which/unction as 
antibody in  an  immune precipitate,  whereas  the  agglutination experiments 
show that it is not exposed on anti-Rh 7G-globulin molecules attached to red 
cells. This suggests that sufficient molecular alteration of the 7G-molecule to 
expose  the  antigen occurs  only when lattice  formation takes place.  Similar 
observations have been made with Milgrom type anti-'r-globulin factors in 
rabbit  sera  (45).  These  do not interact with non-precipitating complexes of 
univalent or bivalent hapten with antihapten antibody (anti-DNP) but reacted 
with the precipitating system of anti-DNP-DNP-BSA. 
Agglutination experiments using red  cells  coated with intact and  pepsin- 
digested incomplete anti-Rh antibodies are useful to study the interaction of 
agglutinating factors with distinct parts of the anti-Rh "},-globulin  molecule (8). 
In  the  present  five  cases,  such  experiments  were  complicated  because  the 
Milgrom type anti-7-globulin factors were associated with potent agglutinators 
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Inhibition experiments indicated that the two substances were distinct. In one 
instance,  a complete separation of the two substances was obtained by DEAE 
cellulose chromatography (of. Fig.  1). The fraction which contained a Milgrom 
type anti-~-globulin factor agglutinated red cells coated with whole anti-CD 
Ripley and other incomplete anti-Rh  antibodies.  It did not agglutinate  cells 
coated with pepsin-digested anti-Rh, thus indicating that the active substance 
reacted with the Fc part of the anti-Rh molecules. 
In the original  paper, Milgrom a  al.  (21) showed that their anti-~-globulin 
factors agglutinated red cells sensitized  with a variety of incomplete antibodies 
(anti-D,  anti-C,  and  some  samples  of  anti-K  and  anti-Fya),  whereas  no 
reactivity was observed with anti-A and anti-B. In view of the known structural 
relationship  between the various immunoglobulins  (32, 33),  reactivity of this 
agglutinator with various molecular forms of human antibodies would provide 
important  evidence for its site of action. In the present experiments,  various 
~,G-globulin antibodies (anti-Rh, anti-A, and anti-B) were found to react with 
Milgrom type anti-'y-globulin factors, whereas no interaction with ~,M-globulin 
antibodies  could be detected in  experiments  with  anti-A,  anti-B,  and  anti- 
Salmonella  O. These findings  also indicate that Milgrom type anti-~-globulin 
factors in human sera react with the Fc part of "yG-globulin since  this part 
gives the molecule its distinctive properties. 
Similar  anti-v-globulin  factors in rabbit sera have been reported to react 
with the Fab fragment of the h,G-globulin molecule  (45, 46). The basis of this 
difference in behavior in the human and rabbit species is at present unknown. 
The inhibition experiments with ~G-globulin aggregated by heat or treatment 
with mercaptoethanol and urea showed that these materials reacted strongly with 
rheumatoid factors, whereas reactivity with the Milgrom type anti-v-globulin 
factors could not be demonstrated. In experiments with similar rabbit sera (45, 
46)  some inhibition was obtained by "y-globulin aggregated by various tech- 
niques, but it was apparent  that large amounts of aggregates had to be used 
to detect a  rather  weak inhibition.  The structural  changes  in the ")'-globulin 
molecule  that  are  required  to  induce  reactivity with  Milgrom  type anti-'y- 
globulin factors thus appear to be highly specific, whereas the changes required 
to increase  the reactivity with rheumatoid factors can be more easily achieved. 
This  is  also  indicated  by absorption  experiments  using  specific precipitates 
containing  human  ~,G-globulin  as  antigen  and  antibody  respectively.  Both 
types  of  complexes  readily  absorbed  rheumatoid  factors,  whereas  only  the 
latter type was able to absorb Milgrom type anti-'y-globulin factors. 
The  three  types of human  anti-'y-globulin  factors discussed  presently are 
clearly  distinguishable  by  inhibition  experiments  and  in  physicochemical 
properties.  Rheumatoid factors detected by the usual serological  procedures 
are "yM-globulins (1, 2) and the same was the case for the present five Milgrom 
type anti-~-globulin factors. The agglutinator active against cells coated with 
pepsin-digested antibodies is more diverse with regard to protein character. It 516  ANTI-'y-GLOBULIN  FACTORS  IN  HUMAN  SERA 
has previously been demonstrated in both the 7S and 19S fractions of serum by 
density gradient  ultracentrifugation  (8).  In  the present experiments,  the ac- 
tivity was found in all three major classes of immunoglobulins.  The diversity in 
physicochemical  properties  of various  forms of anti-7-globulin  factors is an 
intriguing  and as yet unexplained phenomenon. 
The agglutinator  active against red cells coated with pepsin-digested  anti- 
bodies occurs rarely in normal subjects, more frequently in patients with various 
diseases and with a high frequency in rheumatoid arthritis  (cf. Table I). Very 
striking was the observation that strong agglutinators of this kind occurred in 
all five sera that contained Milgrom type anti-w-globulin factbrs. This finding 
may point to a  common stimulus for their formation.  Experimental  (40-44) 
and  clinical  observations  (47, 48)  indicate  that  rheumatoid  factors  may be 
produced as a result of stimulation by autologous antigen-antibody complexes. 
Other  anti-~7-globulin  factors with  somewhat different  serological  properties 
may also be the result of such stimulation. This mechanism appears particularly 
relevant with regard to the agglutinator active against the hidden antigen in 
human "yG-globulin since the absorption experiments showed that this antigen 
also is revealed when human ~G-globulin acts as antibody in an antigen-anti- 
body precipitate. 
It is, however, also possible that enzymatic unmasking of the antigen may 
occur in vivo  in some cases since it has been shown that the intracellular  pH 
during phagocytosis may be as low as 3.5 (49). By immunization with pepsin- 
split autologous ~,G-globulin, rabbits readily produce anti-v-globulin antibodies 
(40). 
SUMMARY 
The serological and physicochemical properties of the following three forms 
of human anti-'g-globulin  factors were compared: (a)  rheumatoid factors;  (b) 
Milgrom type anti-v-globulin factors; and (c) factors directed against an anti- 
gen in human ~,G-globulin that is hidden in the intact molecule and revealed by 
enzymatic digestion at low pH. The property common to these factors is ability 
to  interact  with human  7G-globulin;  they  are  distinguishable  because  they 
react with different antigenic groups on this molecule. 
In all of five sera, the Milgrom type anti-'r-globulin factors were 7M-globu- 
lins.  They reacted with various human ~,G-globulin antibodies but failed to 
interact with -yM-globulin type antibodies in agglutination and absorption ex- 
periments. When isolated from other anti-~,-globulin  factors, they agglutinated 
red cells coated with intact anti-Rh  antibodies, but failed to react with cells 
cells coated with pepsin-digested anti-Rh antibody. These observations indicate 
that  the  agglutinator  reacts  with  the  crystallizable,  inert  fragment  of ~G- 
globulin. 
Anti--y-globulin  activity directed against an antigen in human vG-globulin 
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This anti-~-globulin factor could be absorbed by antigen-antibody precipitates 
containing human antibody, which shows that the hidden antigen in human 
"yG-globulin is revealed not only by enzymatic digestion at low pH, but also 
when "yG-globulin is present as antibody in an antigen-antibody precipitate. 
Rheumatoid factors and Milgrom type anti-~-globulin factors were also  ab- 
sorbed by antigen-antibody precipitates containing human antibody. 
The results indicate that the three distinct forms of anti-~-globu]in factors 
may all be produced as a result of antigenic stimulation by autologous antigen- 
antibody complexes. 
We are indebted to Dr. Marion Waller for a generous gift of anti-CD Ripley, and to Dr. 
A. Eyquem, Dr. 0. Hartmann, and Dr. J. Moullec  for providing the other anti-Rh antibodies. 
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